We collaborate with academia, life sciences, insurances and healthcare providers to deliver solutions for the longevity industry
Copenhagen University Hospital
Hvidovre Hospital is a hospital in the greater Copenhagen area, Denmark. It is one of Denmark's largest hospitals with about 5600 employees, with more than 95.000 patients admitted and 595.000outpatient visits in 2021. It has 35 departments, including Denmark's largest delivery ward with more than 7000 deliveries a year. Hvidovre hospital is part of Copenhagen University Hospital, a conglomerate of several hospitals from the Capital Region and Zealand Region, together with the Faculty of Health and Medical Sciences at the University of Copenhagen. The hospital is a teaching hospital for medical students. Strong clinical research is one of the hospital's pillars. The Department of Clinical Research performs research on the patients’ paths during and after admission, to optimize treatments, with special emphasis on older people with chronic diseases, multimorbid patients with polypharmacy, and people that are acutely admitted to the hospital.
DR. MED. MICHAEL D. WAGENER
Michael Wagener is a board certified general internist and Doctor of Pharmaceutical Medicine. He owns additional training in neuraltherapy, orthomolecular medicine and is external Employee at the Department of Clinical Pharmacology at the University of Zurich.
The focus of his clinic (DR.WAGENER) is the integrative treatment approach of chronic diseases and now the establishment of a treatment strategies and concepts in Longevity Medicine.
In addition he works as a medical consultant and lecturer for various companies and institutions. He is a member of the Board of the SSAAMP (Swiss Society for Antiaging medicine and prevention). Since 2022 he is a member of the scientific advisory board of the Quant Biomarkers company.
PXM - Precise x Med
PXM is an innovation and business strategy partner for digital health solutions and to assist life sciences software and health technology companies to be disruptive in the healthcare industry .
Hadassah believes it has the power to heal our world. That means bringing healing — in every sense of the word — where it’s needed most, in the US, Israel and around the world. Every day. As volunteers. As philanthropists. As changemakers.
The Hadassah Medical Organization’s (HMO) two Jerusalem hospitals are innovative and compassionate global leaders in medical care, treatments and research serving more than a million women, men and children a year, regardless of religion, race or nationality.
University Hospital Basel
The University Hospital Basel is one of five university hospitals in Switzerland and the largest health centre in northwestern Switzerland.
Characteristic is the close connection with the University of Basel and the life sciences companies located in the region, which enables teaching and research at the highest scientific level. There are 44 clinics covering the entire spectrum of human medicine. In addition, there are 8 interdisciplinary treatment centers. It defines seven interdisciplinary focal points in clinic, research and development, from which renowned experts expect significant progress for the future of medicine.
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise.
IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 85,000 employees, IQVIA conducts operations in more than 100 countries.
Pharmaseed is Israel’s largest GLP – certified pre-clinical CRO, specializing in translational projects of all stages, mastering the “end in mind” approach. With over 20 years of experience, a professional team which includes over 13 PHD and postdoctoral level researchers who have held key positions within the life sciences industry, state of the art laboratory, in house vivarium, BL2 safety unit and a modern in vitro laboratory, we are conducting multidisciplinary, complex studies covering molecular, cellular and in vivo needs according to the highest ethical and regulatory standards.
Oberon Sciences' technology is embedded in the proprietary algorithm that improves the effectiveness of drugs. It is a digital system that covers all aspects of precision compliance in health care. The system has been used by over 1000 patients and is supported by software developers and experts.